产品名称
硅酸钙, purum, 12-22% Ca (as CaO) basis, ≥87% SiO2 basis
InChI key
OYACROKNLOSFPA-UHFFFAOYSA-N
InChI
1S/Ca.O3Si/c;1-4(2)3/q+2;-2
SMILES string
[Ca++].[O-][Si]([O-])=O
grade
purum
assay
≥87% SiO2 basis
form
solid
composition
Ca (as CaO), 12-22% T
loss
≤7.0% loss on drying, 2h; 105°C
particle size
7.0-10.0 μm
pH
9.5-11.5 (5% in H2O)
density
2.9 g/mL at 25 °C (lit.)
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
硅酸钙可以用作合成几种生物材料的前体。此类应用的实例包括用于骨组织再生的生物相容性纳米复合材料的制备和溶胶-凝胶杂化生物活性玻璃的合成。
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Emma C Goethals et al.
Langmuir : the ACS journal of surfaces and colloids, 29(2), 658-666 (2012-10-20)
Polymer nanocapsules have gained an important place as drug delivery vehicles for a myriad of biomedical applications. However, the influence of nanocapsule size, wall thickness, and porosity toward controlling the drug delivery efficiency of nanocapsular systems is not well understood.
Rania Hassan Fahmy
AAPS PharmSciTech, 13(3), 990-1004 (2012-07-19)
Multiparticulate floating drug delivery systems have proven potential as controlled-release gastroretentive drug delivery systems that avoid the "all or none" gastric emptying nature of single-unit floating dosage forms. An objective of the presence investigation was to develop calcium silicate (CaSi)/calcium
S S Salek et al.
Applied microbiology and biotechnology, 97(6), 2743-2752 (2012-11-29)
Silicate minerals can be a source of calcium and alkalinity, enabling CO2 sequestration in the form of carbonates. For this to occur, the mineral needs to be first dissolved in an acidifying process such as the biological process of anaerobic
Li Yuan et al.
Langmuir : the ACS journal of surfaces and colloids, 29(2), 734-743 (2012-12-21)
A novel controlled drug-delivery system (CDDS) based on fluorescent mesoporous silica nanoparticles (FMSN) covalently linked with paclitaxel (PTX) via a disulfide linker was designed and characterized. A PTX prodrug based on a disulfide linker was synthesized, and its drug-delivery mechanism
Hongjie Hu et al.
Colloids and surfaces. B, Biointerfaces, 101, 83-90 (2012-07-17)
To improve the bioactivity and cytocompatibility of biomedical titanium dioxide coating, many efforts have been made to modify its surface composition and topography. Meanwhile, CaSiO(3) was commonly investigated as coating material on titanium implants for fast fixation and firm implant-bone
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持